Are we moving towards a new definition of essential medicines?

Journal of Pharmacology and Pharmacotherapeutics

Volumn 6, Issue 3, 2015, Pages 123-125

  Manikandan, S ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CHOICE; DRUG CONTROL; DRUG DOSAGE FORM; DRUG INDICATION; DRUG RESEARCH; ESSENTIAL MEDICINE; HEALTH CARE CONCEPTS; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; OFF LABEL DRUG USE; PRACTICE GUIDELINE; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 84938883823     PISSN: 0976500X     EISSN: 09765018     Source Type: Journal    
DOI: 10.4103/0976-500X.162008     Document Type: Review

References (8)

1. WHO | Essential medicines. WHO. Available from: http://www.who.int/ medicines/services/essmedicines-def/en. [Last accessed on 2015 Jul 4].
2. WHO | World Health Organization. WHO. Available from: http://www. who.int/selection-medicines/en/. [Last accessed on 2015 Jul 4].
3. WHO | Behind the Essential Medicines List. WHO. Available from:http://www.who.int/features/2013/essential-medicines-list/en/. [Last accessed on 2015 Jul 4].
4. WHO Reviews Its Essential Medicines List; Some New Candidates Under Patent. Intellectual Property Watch. Available from: http:// www.ip-watch.org/2015/04/21/who-reviews-its-essential-medicines -list-some-new-candidates-under-patent/. [Last accessed on 2015 Jul 4].
5. Grisanti S, Ziemssen F. Bevacizumab: Off-label use in ophthalmology. Indian J Ophthalmol 2007;55:417-20.
6. Walker SE, Grad HA, Haas DA, Mayer A. Stability of parenteral midazolam in an oral formulation. Anesth Prog 1997;44:17-22.
7. Mingote LR, Namutamba D, Apina F, Barnabas N, Contreras C, Elnour T, et al. The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: A perspective from tuberculosis-affected communities. Lancet 2015;385:477-9.
8. Cavalli P. Prevention of neural tube defects and proper folate periconceptional supplementation. J Prenat Med 2008;2:40-1.